Tagreed Alkaltham: Are You Eligible to Donate Blood?
Tagreed Alkaltham, Transfusion Medicine Lab Supervisor at KSMC, shared a post on LinkedIn:
“Are You Eligible to Donate Blood?
It’s not about perfection.
It’s about safety.
Not everyone can donate blood.
And that’s not a limitation…
It’s protection.
Because in transfusion medicine, safety is never negotiable.
Before you give blood,there is a question that matters more than willingness:
Are you eligible
What does that really mean?
It means your body is ready… and the blood you give is safe for someone who depends on it.
It starts with a simple questionnaire:
Before any test…
before any needle…
You will be asked a few important questions.
Not to judge you…
But to protect you and protect the patient.
Because your answers help determine whether it is the right time for you to donate.
Your health comes first: You should feel well.
No active illness. No recent infections.
Because donation should never harm the donor.
Timing matters: Recent procedures, travel, or medications may require waiting.
Not rejection… just the right time.
Readiness matters:
- Age: 18 and above
- Weight: ≥ 50 kg
Because donation is a physiological process… and the body must be ready.
Before donation… there is a quick check:
Simple.
Routine.
But critical.
- Blood pressure within safe range
- Pulse: regular (60–100 bpm)
- Hemoglobin within acceptable levels
- Temperature: ≤ 37.5°C
- Arm assessment: Both arms are examined for to ensure there are no signs that may compromise recipient safety
This is not just a routine check.
It is a safety filter.
Because in transfusion medicine, every detail matters.
Being deferred…
does not mean being excluded.
It means the system is working exactly as it should.
Not everyone can donate today…
But everyone can be part of saving lives.
Because in the end, the safest blood… is the blood we carefully choose.”
Other posts featuring Tagreed Alkaltham on Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery